Close Menu
Asberth News Network
    Facebook Instagram
    • Home
    • Privacy Policy
    • Terms of use
    • Download App
    Facebook Instagram
    Asberth News Network
    • Home
    • Latest News
    • Breaking News
    • Local News
    • Regional/International News
    • Sports
    • Opinion
    • Back to School
    Asberth News Network
    Home»Main Story»Vaccine trial stopped after neurological symptoms detected
    Main Story

    Vaccine trial stopped after neurological symptoms detected

    September 10, 2020No Comments2 Mins Read
    Facebook Twitter LinkedIn Email Telegram WhatsApp
    Share
    Facebook Twitter LinkedIn Pinterest Email

    LONDON, England (AP) — A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday.

    The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.

    “We don’t know if it is (transverse myelitis),” Kent said. “More tests are being done now as part of the follow-up.”

    On Tuesday, AstraZeneca said its “standard review process triggered a pause to vaccination to allow review of safety data.” It did not provide any details other than to say a single participant had an “unexplained illness.” The vaccine was initially developed by Oxford University after the coronavirus pandemic began this year.

    Kent said an independent committee was reviewing the study’s safety data before deciding if and when the research could continue.

    The study was previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it turned out to be an undiagnosed case of multiple sclerosis that was unrelated to the vaccine.

    Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine in thousands of people in Britain, and in smaller studies in Brazil and South Africa. Several other COVID-19 vaccine candidates are in development.

    Dr Soumya Swaminathan, the World Health Organization’s chief scientist, said the UN health agency wasn’t overly concerned by the pause in the Oxford and AstraZeneca vaccine trial, describing it as “a wake-up call” to the global community about the inevitable ups and downs of medical research.

    Temporary holds of large medical studies aren’t unusual, and investigating any serious or unexpected reaction is a mandatory part of safety testing. AstraZeneca pointed out that it’s possible the problem could be a coincidence; illnesses of all sorts could arise in studies of thousands of people.

    (Source: Jamacia Observer

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

     Dr. Nigel Scott to Lead GYVE Project Following Early Retirement from Community College

    May 9, 2025

      Prime Minister Gonsalves Should Not Undermine What Works for His Caribbean Neighbours

    May 8, 2025

    IRC Hosts Regional Legal Consultation on Establishment of CBI Programme Regulator

    May 8, 2025

    We Can Do Better

    May 8, 2025
    Add A Comment

    Comments are closed.

    • Home
    • Latest News
    • Breaking News
    • Local News
    • Regional/International News
    • Sports
    • Opinion
    • Back to School
    Our Socials
    • Facebook
    • Instagram
    ANN

    Asbert News Network is the premier destination for local, regional and international news in St. Vincent and the Grenadines. It’s tomorrow’s news today.

    © 2025 Asbert News Network
    • Home
    • Privacy Policy
    • Terms of use
    • Download App

    Type above and press Enter to search. Press Esc to cancel.